A healthier world made possible by supersizing the potential of powerful particles

Watch now

Our universal influenza nanovaccine will be effective against more strains of flu

Respiratory infections research

Nanovaccines can prevent parasitic diseases such as malaria and filariasis

Antimicrobial Resistance research

Nanotherapeutics can treat Parkinson's, Alzheimer's, and traumatic brain injury

Neural disorders

We're researching tumor-specific targets for cancer diagnostics and nanotherapeutics

Cancer research

Nanotechnologies can help optimize aging with improved biosensors and vaccine delivery

Aging research

Researching veterinary diseases helps design nanovaccines for similar diseases in humans

Animal health research

Interdisciplinary research

Our research is a transdisciplinary merger of expertise in immunology, nanotechnology, materials science, microbiology, neuroscience, cancer biology, gerontology, clinical science, and social science. We are developing nanovaccines and nanotherapeutics for respiratory infections, neural disorders, antimicrobial resistance, cancer, aging, and animal health.

Our vision is that nanovaccines and nanotherapeutics will revolutionize how we prevent and treat disease.

Collaboration across the United States

The Nanovaccine Institute is a consortium of 84 researchers at 27 universities, research institutes, national laboratories, and companies, founded and coordinated by Iowa State University.

Revolutionizing how we
6 6
Focus Areas
84 84
Researchers
26 26
Institutions
prevent and treat disease